ema

News

Sanofi is celebrating an approval recommendation in the EU for Teizeild, a first-in-class drug designed to delay the progression of type 1 diabetes.

News

Eli Lilly's appeal of a decision by the EMA's human medicines committee not to approve its Alzheimer's disease therapy Kisunla has paid off.

News

Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a MASH treatment.

News

With new guidance, the EMA is seeking to ramp up the inclusion of pregnant and breastfeeding women in clinical trials.

News

The CHMP backed approval of Autolus' leukaemia CAR-T Aucatzyl, as well as drugs from GSK, Roche, SpringWorks, and others, at its May meeting.

Market Access

A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face